Guardant Health (GH) Competitors

Natera (NASDAQ:NTRA) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking, media sentiment and dividends.

Which has preferable earnings & valuation, NTRA or GH?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$1.83B	12.33	-$434.80M	-$1.47	-112.48
Guardant Health	$774.00M	7.89	-$479.45M	-$3.39	-14.54

Does the media refer more to NTRA or GH?

In the previous week, Guardant Health had 5 more articles in the media than Natera. MarketBeat recorded 20 mentions for Guardant Health and 15 mentions for Natera. Natera's average media sentiment score of 1.31 beat Guardant Health's score of 0.61 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	11 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	8 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is NTRA or GH more profitable?

Natera has a net margin of -14.01% compared to Guardant Health's net margin of -59.05%. Natera's return on equity of -26.23% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-14.01%	-26.23%	-14.27%
Guardant Health	-59.05%	-19,157.20%	-25.96%

Does the MarketBeat Community prefer NTRA or GH?

Natera received 188 more outperform votes than Guardant Health when rated by MarketBeat users. However, 71.83% of users gave Guardant Health an outperform vote while only 68.90% of users gave Natera an outperform vote.

Company	Underperform	Outperform
Natera	Outperform Votes 494 68.90%	Underperform Votes 223 31.10%
Guardant Health	Outperform Votes 306 71.83%	Underperform Votes 120 28.17%

Which has more volatility and risk, NTRA or GH?

Natera has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.

Do analysts recommend NTRA or GH?

Natera presently has a consensus target price of $184.63, indicating a potential upside of 11.66%. Guardant Health has a consensus target price of $53.76, indicating a potential upside of 9.07%. Given Natera's higher possible upside, analysts plainly believe Natera is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00
Guardant Health	0 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders and institutionals hold more shares of NTRA or GH?

99.9% of Natera shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 7.6% of Natera shares are held by insiders. Comparatively, 6.1% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Natera beats Guardant Health on 13 of the 17 factors compared between the two stocks.